Farrell G - Search Results

1

CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis.

Zhang X, Shen J, Man K, Chu ES, Yau TO, Sung JC, Go MY, Deng J, Lu L, Wong VW, Sung JJ, Farrell G, Yu J. Zhang X, et al. Among authors: farrell g. J Hepatol. 2014 Dec;61(6):1365-75. doi: 10.1016/j.jhep.2014.07.006. Epub 2014 Jul 15. J Hepatol. 2014. PMID: 25048951 Free article.

2

Pathogenesis and novel treatment options for non-alcoholic steatohepatitis.

Wong VW, Chitturi S, Wong GL, Yu J, Chan HL, Farrell GC. Wong VW, et al. Lancet Gastroenterol Hepatol. 2016 Sep;1(1):56-67. doi: 10.1016/S2468-1253(16)30011-5. Epub 2016 Aug 10. Lancet Gastroenterol Hepatol. 2016. PMID: 28404113 Review.

3

Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.

Ajamieh H, Farrell G, Wong HJ, Yu J, Chu E, Chen J, Teoh N. Ajamieh H, et al. Among authors: farrell g. J Gastroenterol Hepatol. 2012 Aug;27(8):1353-61. doi: 10.1111/j.1440-1746.2012.07123.x. J Gastroenterol Hepatol. 2012. PMID: 22432744

4

Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.

Zhang N, Chu ES, Zhang J, Li X, Liang Q, Chen J, Chen M, Teoh N, Farrell G, Sung JJ, Yu J. Zhang N, et al. Among authors: farrell g. Oncotarget. 2014 Sep 30;5(18):8330-40. doi: 10.18632/oncotarget.2212. Oncotarget. 2014. PMID: 25327562 Free PMC article.

5

Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling.

Liang JQ, Teoh N, Xu L, Pok S, Li X, Chu ESH, Chiu J, Dong L, Arfianti E, Haigh WG, Yeh MM, Ioannou GN, Sung JJY, Farrell G, Yu J. Liang JQ, et al. Among authors: farrell g. Nat Commun. 2018 Oct 26;9(1):4490. doi: 10.1038/s41467-018-06931-6. Nat Commun. 2018. PMID: 30367044 Free PMC article.

6

Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitis.

Yu J, Chu ES, Hui AY, Cheung KF, Chan HL, Leung WK, Farrell GC, Sung JJ. Yu J, et al. Biochem Biophys Res Commun. 2007 Apr 27;356(1):53-9. doi: 10.1016/j.bbrc.2007.02.129. Epub 2007 Mar 5. Biochem Biophys Res Commun. 2007. PMID: 17350593

7

Acute atorvastatin is hepatoprotective against ischaemia-reperfusion injury in mice by modulating eNOS and microparticle formation.

Ajamieh H, Farrell GC, McCuskey RS, Yu J, Chu E, Wong HJ, Lam W, Teoh NC. Ajamieh H, et al. Liver Int. 2015 Sep;35(9):2174-86. doi: 10.1111/liv.12827. Epub 2015 Apr 7. Liver Int. 2015. PMID: 25786512

8

Mouse models of non-alcoholic steatohepatitis: A reflection on recent literature.

Haczeyni F, Yeh MM, Ioannou GN, Leclercq IA, Goldin R, Dan YY, Yu J, Teoh NC, Farrell GC. Haczeyni F, et al. J Gastroenterol Hepatol. 2018 Jul;33(7):1312-1320. doi: 10.1111/jgh.14122. Epub 2018 Mar 24. J Gastroenterol Hepatol. 2018. PMID: 29424123 Free article. Review.

9

COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.

Yu J, Ip E, Dela Peña A, Hou JY, Sesha J, Pera N, Hall P, Kirsch R, Leclercq I, Farrell GC. Yu J, et al. Hepatology. 2006 Apr;43(4):826-36. doi: 10.1002/hep.21108. Hepatology. 2006. PMID: 16557554

10

PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.

Shen B, Chu ES, Zhao G, Man K, Wu CW, Cheng JT, Li G, Nie Y, Lo CM, Teoh N, Farrell GC, Sung JJ, Yu J. Shen B, et al. Among authors: farrell gc. Br J Cancer. 2012 Apr 24;106(9):1486-94. doi: 10.1038/bjc.2012.130. Br J Cancer. 2012. PMID: 22472882 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

723 results

Search Page

Filters